The Non-Malignant Channel is supported with funding from Agios (Gold).
The Sickle Cell Disease Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BSH 2019 | Chou lab research and updates: alloimmunization prevention
Stella Chou
• 2 Apr 2019
Stella Chou, MD, University of Pennsylvania, Philadelphia, PA, tells us about the ongoing research at her lab, including alloimmunization prevention and transfusion safety for patients with sickle cell disease using genomics.
